Abstract:Aims Haploinsufficiency of the chromo-domain protein CHD7 underlies most cases of CHARGE syndrome, a multisystem birth defect including congenital heart malformation. Context specific roles for CHD7 in various stem, progenitor and differentiated cell lineages have been reported. Previously we showed severe defects when Chd7 is absent from cardiopharyngeal mesoderm (CPM). Here we investigate altered gene expression in the CPM and identify specific CHD7-bound target genes with known roles in the morphogenesis of affected structures. Methods and results We generated conditional KO of Chd7 in CPM and analysed cardiac progenitor cells using transcriptomic and epigenomic analyses, in vivo expression analysis, and bioinformatic comparisons with existing datasets. We show CHD7 is required for correct expression of several genes established as major players in cardiac development, especially within the second heart field (SHF). We identified CHD7 binding sites in cardiac progenitor cells and found strong association with histone marks suggestive of dynamically regulated enhancers during the mesodermal to cardiac progenitor transition of mESC differentiation. Moreover, CHD7 shares a subset of its target sites with ISL1, a pioneer transcription factor in the cardiogenic gene regulatory network, including one enhancer modulating Fgf10 expression in SHF progenitor cells versus differentiating cardiomyocytes. Conclusion We show that CHD7 interacts with ISL1, binds ISL1-regulated cardiac enhancers and modulates gene expression across the mesodermal heart fields during cardiac morphogenesis. Translational Perspective CHD7 is a chromatin remodeller haploinsufficient in CHARGE syndrome and implicated in autism spectrum disorder and various cancers. Heart defects in the syndrome are recapitulated by murine loss-of-function in two linages, neural crest and cardiopharyngeal mesoderm (CPM). CHD7 regulates vital cardiogenic genes via binding predominantly to enhancers distant from the target gene at sites often shared with the pioneer transcription factor ISL1. CHD7 bound enhancer elements show highly dynamic switching of histone modifications during the mesodermal to cardiac progenitor cell transition. Thus, manipulation of CHD7 activity may assist in directed differentiation of distinct cardiovascular progenitors for use in regenerative/repair therapeutics.

The mutation in Chd7 causes misexpression of Bmp4 and developmental defects in telencephalic midline.

Pervasive cortical and white matter anomalies in a mouse model for CHARGE syndrome

Chd7 is Indispensable for Mammalian Brain Development Through Activation of a Neuronal Differentiation Programme

Establishment of an Induced Pluripotent Stem Cell Line from a Patient with CHARGE Syndrome Carrying a CHD7 (p.l1151gfs*17) Mutation

De Novo Splice Site Mutation of the CHD7 Gene in a Chinese Patient with Typical CHARGE Syndrome

CHD7 Promotes Neural Progenitor Differentiation in Embryonic Stem Cells Via Altered Chromatin Accessibility and Nascent Gene Expression.

Deletion of the chd7 Hinders Oligodendrocyte Progenitor Cell Development and Myelination in Zebrafish

CHD7 regulates craniofacial cartilage development via controlling HTR2B expression

Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination

Morphological and sensorimotor phenotypes in a zebrafish CHARGE syndrome model are domain-dependent

Chd7 Is Critical for Early T-Cell Development and Thymus Organogenesis in Zebrafish.

Sema3E is required for migration of cranial neural crest cells in zebrafish: Implications for the pathogenesis of CHARGE syndrome

CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression

Mutation update on the CHD7 gene involved in CHARGE syndrome

Versatile Roles of the Chromatin Remodeler CHD7 during Brain Development and Disease.

CHD7 deficiency in "Looper", a new mouse model of CHARGE syndrome, results in ossicle malformation, otosclerosis and hearing impairment

Feeding difficulty is the dominant feature in 12 Chinese newborns with CHD7 pathogenic variants

Non-Homologous End Joining Repair Mechanism-Mediated Deletion of CHD7 Gene in a Patient with Typical CHARGE Syndrome

CHD7 Represses the Retinoic Acid Synthesis Enzyme ALDH1A3 During Inner Ear Development.

CHD7 regulates otic lineage differentiation and deafness gene expression in human inner ear organoids

Mutations in a new member of the chromodomain gene family cause CHARGE syndrome